Related Experiment Video
Updated: Jun 26, 2026

Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines
Published on: November 25, 2017
[Macroamylasaemia in paediatrics]
A Torrent Vernetta1, O Segarra Cantón, P Soler Palacín
1Unitat de Gastroenterologia, Hepatologia i Suport a la Nutrició Pediàtrica, Hospital Universitari Vall d'Hebron, Barcelona, Spain. atorrentvernetta@hotmail.com
Abstract:
Macroamylasaemia should be considered in any patient with high plasma amylase, no clinical signs and negative additional investigations for pancreatic or parotid diseases. It is characterised by an increase in serum amylase due to circulating high molecular mass macrocomplexes, most often formed due the binding of the amylase to an immunoglobulin. With a normal renal function, a hyperamylasaemia without an increase in urine amylase suggests the diagnosis, and is confirmed by identifying the macromolecular components. It is an uncommon entity in paediatrics. It has been described as a casual finding associated to abdominal pain and to celiac disease. We report two paediatric cases of macroamylasaemia, and a review of the tests needed for its diagnosis. The better understanding of this biochemical anomaly allows us to differentiate it from other situations associated to hyperamylasaemia, in order to avoid additional invasive explorations and unnecessary treatments.
Related Concept Videos
Inborn Errors of Metabolism
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Hyperglycemia
Hypoglycemia and Glucagon
Acute Pancreatitis II: Clinical Manifestations and Management
